Artificial Intelligence Reduces Costs and Accelerates Time to Market

whitePaper | April 19, 2023

Unplanned downtime is one of the most significant pain points for industrial manufacturers today, costing them an estimated $50 billion each year. The risk is even greater for process manufacturing, where a critical equipment failure could result in the loss of an entire batch, environmental hazards, or safety risks. The adoption of digital technologies, such as the industrial internet of things (IIoT), promises to mitigate these threats by forecasting equipment failures and catching faults before they lead to unscheduled shutdowns. However, in practice, several challenges arise when maintenance personnel and operations leaders work to implement an IIoT solution aimed at eliminating unplanned downtime.

whitePaper | August 26, 2022

For all business leaders, the past two years have been filled with trial and error as we continue to navigate this unprecedented time of health and safety, regulations, and shifting consumer needs. As the global economy seeks stability throughout the fluid pandemic mandates, we are finding that high-quality data has been a key play to keeping customer centricity.

whitePaper | September 7, 2022

Today, organizations are increasingly seeking technologies that simplify the deployment of their application workloads in a multi-cloud design to get lower TCO, build best-of-breed solutions, and avoid vendor lock-in. Whether to optimize the costs of running and managing private cloud or to enable developer velocity to efficiently build the modern, intelligent applications of tomorrow, the benefits of multi-cloud offerings are an attractive proposition for enterprises.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | August 25, 2022

Everyday user experiences are being completely reimagined. Requesting a ride through an app is better than calling a cab. Buying online is changing the way we go shopping. And gone are the days of waiting in long lines at your local bank. Data within these modern businesses is in constant motion, flowing, in real-time, across systems, environments, and applications every time a user interacts with the system.

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....